MarketCap
Facebook
X
TelegramQuarterly report 2023-Q3
added 11-13-2023
Eloxx Pharmaceuticals P/B Ratio 2011-2025 | ELOX
Annual P/B Ratio Eloxx Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.577 | 0.0555 | 13.5 | 4.11 | 8.72 | 7.46 | 0.802 | 0.873 | 0.414 | 1.08 | 6.45 | 3.99 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 13.5 | -0.577 | 3.91 |
P/B Ratio of other stocks in the Biotechnology industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
ARCA biopharma
ABIO
|
1.27 | - | 1052.0 % | $ 415 M |  USA |
 |
AbbVie
ABBV
|
2.53 | $ 223.98 | -0.53 % | $ 396 B | USA |
 |
Alpine Immune Sciences
ALPN
|
1.5 | - | - | $ 2.17 B | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
4.2 | $ 4.67 | 1.74 % | $ 775 M |  Canada |
 |
Aclaris Therapeutics
ACRS
|
0.979 | $ 3.36 | 2.75 % | $ 260 M | USA |
 |
AlloVir
ALVR
|
0.432 | - | 4.14 % | $ 49.1 M | USA |
 |
Acasti Pharma
ACST
|
0.612 | - | 4.01 % | $ 150 M | Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
51.9 | - | -15.15 % | $ 60.3 M |  Britain |
 |
Ampio Pharmaceuticals
AMPE
|
0.198 | - | -11.43 % | $ 502 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | USA |
 |
Albireo Pharma
ALBO
|
3.06 | - | -0.23 % | $ 916 M | USA |
 |
Ascendis Pharma A/S
ASND
|
8.34 | $ 210.16 | 4.43 % | $ 5 B |  Danmark |
 |
Ayala Pharmaceuticals
AYLA
|
0.994 | - | - | $ 7.46 M |  Israel |
 |
Aptorum Group Limited
APM
|
0.347 | $ 1.33 | -1.48 % | $ 7.25 M |  China |
 |
Alterity Therapeutics Limited
ATHE
|
125 | $ 3.42 | 2.09 % | $ 8.23 B |  Australia |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
1.79 | $ 25.9 | 0.74 % | $ 1.25 B | USA |
 |
AstraZeneca PLC
AZN
|
2.07 | $ 90.29 | - | $ 96.9 B | Britain |
 |
Anika Therapeutics
ANIK
|
1.38 | $ 9.49 | - | $ 139 M | USA |
 |
Brickell Biotech
BBI
|
0.982 | - | -5.38 % | $ 6.06 M | USA |
 |
BeiGene, Ltd.
BGNE
|
75.9 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Bellicum Pharmaceuticals
BLCM
|
0.415 | - | -9.72 % | $ 5.89 M | USA |
 |
Berkeley Lights
BLI
|
0.824 | - | -7.31 % | $ 87 M | USA |
 |
Aytu BioScience
AYTU
|
0.127 | $ 2.28 | - | $ 14.3 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
7.2 | - | -6.81 % | $ 3.04 B | USA |
 |
Biogen
BIIB
|
1.16 | $ 172.5 | - | $ 25.1 B | USA |
 |
Baudax Bio
BXRX
|
-0.0321 | - | 0.59 % | $ 63 K | USA |
 |
Avenue Therapeutics
ATXI
|
0.293 | - | -52.27 % | $ 4.45 M | USA |
 |
Benitec Biopharma
BNTC
|
5.72 | $ 12.96 | 1.17 % | $ 533 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - |  Russia |
 |
ChromaDex Corporation
CDXC
|
9.34 | - | -0.88 % | $ 598 M | USA |
 |
Axon Enterprise
AXON
|
17.1 | $ 581.03 | 2.22 % | $ 44 B | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
32 | $ 0.29 | -0.31 % | $ 631 M | Israel |
 |
Checkpoint Therapeutics
CKPT
|
-12.7 | - | - | $ 169 M | USA |
 |
Caladrius Biosciences
CLBS
|
0.122 | - | -16.75 % | $ 25.8 M | USA |
 |
Catalyst Biosciences
CBIO
|
0.428 | $ 15.31 | - | $ 1.01 B | USA |
 |
Clovis Oncology
CLVS
|
-0.829 | - | -7.23 % | $ 13 M | USA |
 |
Cerus Corporation
CERS
|
5.29 | $ 2.15 | 13.76 % | $ 397 M | USA |
 |
BioVie
BIVI
|
0.128 | $ 1.51 | -4.43 % | $ 2.23 M | USA |
 |
Cortexyme
CRTX
|
0.823 | - | -1.05 % | $ 67.1 M | USA |
 |
Celldex Therapeutics
CLDX
|
0.00176 | $ 27.94 | - | $ 1.8 M | USA |
 |
Cellectar Biosciences
CLRB
|
-3.23 | $ 3.78 | -5.97 % | $ 46.2 M | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
3.42 | - | - | $ 2.18 B | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-12.6 | $ 11.44 | 7.92 % | $ 740 M | USA |
 |
BioNTech SE
BNTX
|
5.29 | $ 96.0 | - | $ 27.2 B |  Germany |
 |
Acer Therapeutics
ACER
|
-0.724 | - | 2.71 % | $ 14 M | USA |
 |
Enochian Biosciences
ENOB
|
-5.41 | - | - | $ 40.5 M | USA |
 |
Epizyme
EPZM
|
0.355 | - | - | $ 249 M | USA |